| MNTA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the MNTA shares outstanding history going back to 2/26/2010:
Also see: MNTA Market Cap History MNTA YTD Return |
MNTA Shares Outstanding History — Momenta Pharmaceuticals Share Count Over Time
As of 8/3/2020 Momenta Pharmaceuticals has 118.85 million MNTA shares outstanding. Investors often track the MNTA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows MNTA share count trends over time, with 46 historical shares outstanding datapoints presented, dating back to 2/26/2010.
| MNTA Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MNTA Historical Shares Outstanding: +9.79% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MNTA Stock Price Chart |
| About Momenta Pharmaceuticals Inc |
| Momenta Pharmaceuticals is a biotechnology company focused on the discovery and development of biologic therapies for the treatment of rare immune-mediated diseases. Co.'s programs include: M281, a fully-human anti-neonatal Fc receptor, aglycosylated immunoglobulin G (IgG1), monoclonal antibody; M254, a hyper-sialylated immunoglobulin; M230, a novel recombinant trivalent human IgG1 Fc multimer; and M710, a biosimilar of EYLEA, a vascular endothelial growth factor inhibitor indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration, Macular Edema following Retinal Vein Occlusion, Diabetic Macular Edema (DME), and Diabetic Retinopathy in patients with DME. We show 46 historical shares outstanding datapoints in our coverage of MNTA's shares outstanding history. Understanding the changing numbers of MNTA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MNTA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MNTA by allowing them to research MNTA shares outstanding history as well as any other stock in our coverage universe. |
| MNTA Current Stock Quote |
Quotes delayed 20 minutes  Free MNTA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| MNTA Share Performance |
| Shares Outstanding Peers |
| Momenta Pharmaceuticals (MNTA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
MODD Shares Outstanding History MODV Shares Outstanding History MOH Shares Outstanding History MORF Shares Outstanding History MOTS Shares Outstanding History MOVE Shares Outstanding History MRIC Shares Outstanding History MRK Shares Outstanding History MRKR Shares Outstanding History MRNA Shares Outstanding History More Healthcare companies » |
MNTA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
